Using Video Images to Improve Advance Care Planning in Patients With Cancer
This study has been completed.
Information provided by (Responsible Party):
Angelo E. Volandes, MD, Massachusetts General Hospital
First received: August 6, 2009
Last updated: April 28, 2012
Last verified: April 2012
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
||Using Video Images to Improve Advance Care Planning in Patients With Cancer
Primary Outcome Measures:
- end of life preference at time of interview [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- knowledge [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
- decisional conflict [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2011 (Final data collection date for primary outcome measure)
Experimental: Cancer subjects
outline of the goals of care
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.
|Ages Eligible for Study:
||21 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:
- All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
- Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
- Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
- The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
- Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
- English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
- Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
- Able to provide informed consent.
- Age greater than or equal to 21.
- MMSE < 25.
- Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00970125
|Memorial Sloan Kettering
|New York, New York, United States, 10065 |
Massachusetts General Hospital
||Angelo E. Volandes, MD, MPH
||Massachusetts General Hospital
No publications provided
||Angelo E. Volandes, MD, Faculty, Massachusetts General Hospital
History of Changes
|Other Study ID Numbers:
||2008-P-002156/2, R21 CA 139121-01
|Study First Received:
||August 6, 2009
||April 28, 2012
||United States: Institutional Review Board
Keywords provided by Massachusetts General Hospital:
ClinicalTrials.gov processed this record on November 24, 2014
advance care planning